This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
CHIMIA (Jan 2000)
Affiliations
Read online
Three examples are used to show how the coordination chemist can develop macrocyclic ligands for labeling monoclonal antibodies used in nuclear medicine for tumor diagnosis and therapy.